ConductScience.org, home

Paper36922675

KIF14 promotes proliferation, lymphatic metastasis and chemoresistance through G3BP1/YBX1 mediated NF-κB pathway in cholangiocarcinoma.

Jiang W and 12 others. Oncogene, 2023. Cited by 44 papers, by iCite.

Cite this record

ConductScience Library. KIF14 promotes proliferation, lymphatic metastasis and chemoresistance through G3BP1/YBX1 mediated NF-κB pathway in cholangiocarcinoma. Papers, record 36922675. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36922675

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
KIF14 promotes proliferation, lymphatic metastasis and chemoresistance through G3BP1/YBX1 mediated NF-κB pathway in cholangiocarcinoma.
PubMed
Journal
Oncogene
PubMed
Year
2023
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
44
iCite
Relative citation ratio, by iCite
4
iCite
Revised in PubMed
2026-10-30
PubMed

Authors13

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Jiang WWangjie
2Wang JJifei
3Yang XXiao
4Shan JJijun
5Zhang YYaodong
6Shi XXiaoli
7Wang YYuming
8Chenyan AAnlan
9Chang JJiang
10Wang YYirui
11Yu YYue
12Li CChangxian
13Li XXiangchenghttps://orcid.org/0000-0002-8878-7332

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Bile Duct NeoplasmsMajor topic
CholangiocarcinomaMajor topic
Humans
NF-kappa B
Lymphatic Metastasis
DNA Helicases
Drug Resistance, Neoplasm
RNA Helicases
Poly-ADP-Ribose Binding Proteins
RNA Recognition Motif Proteins
Cell Proliferation
Bile Ducts, Intrahepatic
Cell Line, Tumor
Cell Movement
Tumor Microenvironment
Y-Box-Binding Protein 1
Oncogene Proteins
Kinesins

Source PubMed

Download CSV of topics

References45

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123483479NF-κB and STAT3 signaling pathways collaboratively link inflammation to cancer.Protein Cell2013https://conductscience.org/library/papers/23483479PubMed
229123259Tumour-infiltrating inflammatory and immune cells in patients with extrahepatic cholangiocarcinoma.Br J Cancer2018https://conductscience.org/library/papers/29123259PubMed
334352206N7-Methylguanosine tRNA modification enhances oncogenic mRNA translation and promotes intrahepatic cholangiocarcinoma progression.Mol Cell2021https://conductscience.org/library/papers/34352206PubMed
433692217Tumor-associated neutrophils and macrophages interaction contributes to intrahepatic cholangiocarcinoma progression by activating STAT3.J Immunother Cancer2021https://conductscience.org/library/papers/33692217PubMed
534011528Flightless I Homolog Reverses Enzalutamide Resistance through PD-L1-Mediated Immune Evasion in Prostate Cancer.Cancer Immunol Res2021https://conductscience.org/library/papers/34011528PubMed
630226594KIF14 promotes cell proliferation via activation of Akt and is directly targeted by miR-200c in colorectal cancer.Int J Oncol2018https://conductscience.org/library/papers/30226594PubMed
723209302KIF14 negatively regulates Rap1a-Radil signaling during breast cancer progression.J Cell Biol2012https://conductscience.org/library/papers/23209302PubMed
833380832KIF14 and KIF23 Promote Cell Proliferation and Chemoresistance in HCC Cells, and Predict Worse Prognosis of Patients with HCC.Cancer Manag Res2020https://conductscience.org/library/papers/33380832PubMed
933431577Placental growth factor promotes tumour desmoplasia and treatment resistance in intrahepatic cholangiocarcinoma.Gut2022https://conductscience.org/library/papers/33431577PubMed
1031043744CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy.Nature2019https://conductscience.org/library/papers/31043744PubMed
1128382490
Silencing of Y-box binding protein-1 by RNA interference inhibits proliferation, invasion, and metastasis, and enhances sensitivity to cisplatin through NF-κB signaling pathway in human neuroblastoma SH-SY5Y cells.
Mol Cell Biochem2017https://conductscience.org/library/papers/28382490PubMed
1234287041Orf Virus ORF120 Protein Positively Regulates the NF-κB Pathway by Interacting with G3BP1.J Virol2021https://conductscience.org/library/papers/34287041PubMed
1334131133Structural basis of mechano-chemical coupling by the mitotic kinesin KIF14.Nat Commun2021https://conductscience.org/library/papers/34131133PubMed
1432690952The NK cell-cancer cycle: advances and new challenges in NK cell-based immunotherapies.Nat Immunol2020https://conductscience.org/library/papers/32690952PubMed
1533020468G3BP1 controls the senescence-associated secretome and its impact on cancer progression.Nat Commun2020https://conductscience.org/library/papers/33020468PubMed
1633431813BUB1B promotes extrahepatic cholangiocarcinoma progression via JNK/c-Jun pathways.Cell Death Dis2021https://conductscience.org/library/papers/33431813PubMed
1723315968Hepatocyte nuclear factor 4 alpha deletion promotes diethylnitrosamine-induced hepatocellular carcinoma in rodents.Hepatology2013https://conductscience.org/library/papers/23315968PubMed
1833264573Pathogenesis of Cholangiocarcinoma.Annu Rev Pathol2021https://conductscience.org/library/papers/33264573PubMed
1931113805Targeting the YB-1/PD-L1 Axis to Enhance Chemotherapy and Antitumor Immunity.Cancer Immunol Res2019https://conductscience.org/library/papers/31113805PubMed
2034413131GM-CSF drives myelopoiesis, recruitment and polarisation of tumour-associated macrophages in cholangiocarcinoma and systemic blockade facilitates antitumour immunity.Gut2022https://conductscience.org/library/papers/34413131PubMed

See all 45 referencesDownload CSV of references

Cited by26

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 44 citations.

PMIDTitleJournalYearIn PapersSource
42698848YBX1 as an adaptive RNA hub in cancer: linking state-dependent RNA regulation to tumor immunity, metabolic reprogramming, and therapy resistance.Front Immunol2026https://conductscience.org/library/papers/42698848PubMed
42511704Advances in the Molecular Mechanisms of Cholangiocarcinoma: A Comprehensive Review of Biomarkers, Regulatory Pathways and Tumor Microenvironment Reprogramming.Int J Mol Sci2026https://conductscience.org/library/papers/42511704PubMed
42180604Multi-stage transcriptome analysis identifies hub genes and regulatory mechanisms driving cervical cancer progression.PeerJ2026https://conductscience.org/library/papers/42180604PubMed
42107065G3BP1 Succinylation at K413 is Critical for Cardiac Function by Modulating PI3K-AKT-mTOR Signal Axis.Adv Sci (Weinh)2026https://conductscience.org/library/papers/42107065PubMed
42036047Ubiquitin E3 ligase MYCBP2 targets KIF14 and contributes to acute myeloid leukemia progression.J Biol Chem2026https://conductscience.org/library/papers/42036047PubMed
41513625RECQL4 promotes the malignant progression of lung adenocarcinoma through the YBX1/G3BP1-mediated NF-κB signaling pathway.Cell Death Discov2026https://conductscience.org/library/papers/41513625PubMed
41511650KIF14 in cancer biology: implications for diagnosis and therapy.Clin Exp Metastasis2026https://conductscience.org/library/papers/41511650PubMed
41507134YBX1 orchestrates LDHA-mediated metabolic reprogramming and NF-κB activation to drive clear cell renal cell carcinoma progression.Cell Death Dis2026https://conductscience.org/library/papers/41507134PubMed
41410179Validation of the important role and prognostic value of KIF14 in triple-negative breast cancer.Cancer Biol Ther2025https://conductscience.org/library/papers/41410179PubMed
41243224CD169+ Macrophage-Targeted Immunomodulator to Restore Phagocytic Function and Enhance Antigen Presentation for Lymphatic Metastasis Eradication.Adv Sci (Weinh)2026https://conductscience.org/library/papers/41243224PubMed
41049446PRDX3 Promotes Lymph Node Metastasis in Cervical Cancer by Activating NF-κB Signaling Pathway and Anoikis Resistance.Int J Med Sci2025https://conductscience.org/library/papers/41049446PubMed
41026307Identification of KIF14 as a ferroptosis biomarker for predicting the prognosis and immunotherapy efficacy of bladder cancer.Discov Oncol2025https://conductscience.org/library/papers/41026307PubMed
40974432Kinesin superfamily proteins in ovarian cancer: from molecular mechanisms to clinical applications.Med Oncol2025https://conductscience.org/library/papers/40974432PubMed
40951482Cytoarchitectural changes in the developing cerebellar cortex of the laggard mutant mouse.Narra J2025https://conductscience.org/library/papers/40951482PubMed
40799245YBX1: an RNA/DNA-binding protein that affects disease progression.Front Oncol2025https://conductscience.org/library/papers/40799245PubMed
40783393EPS8L2 drives colorectal cancer cell proliferation and migration via YBX1-dependent activation of G3BP2 transcription.Cell Death Dis2025https://conductscience.org/library/papers/40783393PubMed
40707677Pan-cancer analysis of UGGT1 in human tumors and experimental validation in breast cancer.Sci Rep2025https://conductscience.org/library/papers/40707677PubMed
40374610Identification of tRF-29-79MP9P9NH525 as a biomarker and tumor suppressor of gastric cancer via regulating KIF14/AKT pathway.Cell Death Discov2025https://conductscience.org/library/papers/40374610PubMed
40292920Elevated KIF2C Expression Drives Osteosarcoma Progression by Modulating the Wnt/β-Catenin Signaling Pathway and Contributing to an Immunosuppressive Tumor Microenvironment.Cancer Med2025https://conductscience.org/library/papers/40292920PubMed
39948570TNFAIP2 promotes NF-κB signaling mediate lymph node metastasis of oral squamous cell carcinoma by protecting IKKβ from ubiquitin proteasome degradation.Cell Commun Signal2025https://conductscience.org/library/papers/39948570PubMed

See all 26 cited byDownload CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
G3BP110146PubTator's text mininghttps://conductscience.org/library/genes/10146NCBI Gene
HNF4A3172PubTator's text mininghttps://conductscience.org/library/genes/3172NCBI Gene
KIF149928PubTator's text mininghttps://conductscience.org/library/genes/9928NCBI Gene
NFKB14790PubTator's text mininghttps://conductscience.org/library/genes/4790NCBI Gene
YBX14904PubTator's text mininghttps://conductscience.org/library/genes/4904NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36922675

GET https://conductscience.org/api/papers/v1/36922675/references?page=2